Dr. Emmanuelle Charpentier and Dr. Jennifer A. Doudna make history as the first all-female team to be awarded the Nobel Prize in Chemistry for their pioneering discovery of CRISPR-Cas9, a highly specific and efficient genome editing technology.
You can read the full article by Jean Paul and Amanda at the following link: How CRISPR Is Revolutionizing Our Study Of Complex Diseases, Like Alzheimer’s.